Hematopoietic stem cell transplantation for the treatment of autoimmune diseases

References

• Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 5th ed. Baltimore: Williams & Wilkins; 1997.
   Google Scholar
• Lahita RG, editor. Systemic lupus erythematosus. 3rd ed. San Di-ego: Academic Press; 1998.
   Google Scholar
• Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus; results from a single cen-tre. I. Causes of death. J Ftheumatol 1995;22:1259–64.
   Google Scholar
• Gladman DD. Prognosis and treatment of systemic lupus erythe-matosus. Curr Opin Ftheumatol 1996;8:430–7.
   Google Scholar
• Godfrey T, Khamashta MA, Hughes GRV. Therapeutic advances in systemic lupus erythematosus. Curr Opin Ftheumatol 1998;10: 435–41.
   PubMedGoogle Scholar
• Bulman PM, Hunder G. New approaches for treatment of systemic lupus erythematosus. Ann Intern Med 1998;129:1095–6.
   Google Scholar
• Illei GG, Klippel JH. Novel approaches in the treatment of lupus nephritis. Lupus 1998;7:644–8.
   PubMed Web of Science ®Google Scholar
• Snowden JA, Biggs JC, Brooks PM. Autologous blood stem cell transplantation for autoimmune diseases. Lancet 1996;348:1112–3.
   Google Scholar
• Burt RK. BMT for severe autoimmune diseases: an idea whose time has come. Oncology 1997;11:1001–17.
   PubMedGoogle Scholar
• Marmont AM. Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases. J Ftheumatol 1997;24 Suppl 48:13–8.
   Google Scholar
• Brooks PM. Hematopoietic stem cell transplantation for autoim-mune diseases. J Ftheumatol 1997;24 Suppl 48:19–22.
   Google Scholar
• Tyndall A. Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythema-tosus. J Ftheumatol 1997;24 Suppl 48:94–7.
   Google Scholar
• Wicks I, Cooley H, Szer J. Autologous hemopoietic stem cell trans-plantation. Arthritis Rheum 1997;40:1005–11.
   Google Scholar
• Van Bekkum DW. New opportunities for the treatment of severe autoimmune diseases: bone marrow transplantation. Clin Immunol Immunopathol 1998;89:1–10.
   Google Scholar
• Ikehara S. Bone marrow transplantation for autoimmune diseases. Acta Haematol 1998;99:116–32.
   PubMed Web of Science ®Google Scholar
• Burt RK, Traynor AE. Hematopoietic stem cell transplantation: a new therapy for autoimmune disease. Oncologist 1999;4:77–83.
   Google Scholar
• Krance R, Brenner M. BMT beats autoimmune disease. Nature Med 1998;4:153–5.
   PubMedGoogle Scholar
• Marmont AM. Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 1998;83:733–43.
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Petri M, Jones RJ. Hematopoietic stem cell trans-plantation for systemic lupus erythematosus. Rheum Dis Clin North Am 2000;26:377–87.
   Google Scholar
• Denman AM, Russell AS, Denman EJ. Adoptive transfer of the 41. disease of New Zealand Black mice to normal mouse strains. Clin Exp Immunol 1969;5: 567–95.
   Google Scholar
• Ikehara S, Good RA, Nakamura T, Sekita K, Inoue S, Maung Maung OO, et al. Rationale for bone marrow transplantation in the 42. treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985;82: 2483–7.
   Google Scholar
• Ikehara S, Yasumizu R, Inaba M, Izui S, Hayakawa K, Sekita K, et al. Long-term observations of autoimmune-prone mice treated for 43. autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1989;86:3306–10.
   PubMed Web of Science ®Google Scholar
• Adachi Y, Inaba M, Inaba K, Soe than, Kobayashi Y, Ikehara S. Analyses of thymic abnormalities in autoimmune-prone (NZW X 44. BXSB)F1 mice. Immunobiology 1993;188:340–54.
   Google Scholar
• Van Bekkum DW, Bohre EPM, Houben PFJ, Knaan-Shanzer S. Regression of ajuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci USA 1989;86:10090-4.45.
   Google Scholar
• Knaan-Shanzer S, Houben P, Kinwel-Bohre EPM, Van Bekkum DW. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991;8:333-8.46.
   Google Scholar
• Van Gelder M, Van Bekkum DW. Treatment of relapsing experi-mental autoimmune encephalomyelitis in rats with allogeneic bone 47. marrow transplantation from a resistant strain. Bone Marrow Transplant 1995;16:343–51.
   PubMed Web of Science ®Google Scholar
• Van Gelder M, Mulder AH, Van Bekkum DW. Treatment of 48. relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation. Transplantation 1996;62:810–8.
   Google Scholar
• Van Gelder M, Kinwel-Bohre EPM, Van Bekkum DW. Treatment 49. of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 1993;11: 233-41.50.
   Google Scholar
• Van Gelder M, Van Bekkum DW. Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautolo-gous bone marrow transplantation. Bone Marrow Transplant 51. 1996;18:1029–34.
   PubMed Web of Science ®Google Scholar
• Kamiya M, Sohen S, Yamane T, Tanaka S. Effective treatment of mice with type II collagen-induced arthritis with lethal irradiation and bone marrow transplantation. J Ftheumatol 1993;20:225-30.52.
   Google Scholar
• Baldwin JL, Storb R, Thomas ED, Mannik M. Bone marrow trans-plantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977;20:1043–8.
   PubMed Web of Science ®Google Scholar
• Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogenic bone marrow 53. transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1986;1: 237–9.
   Google Scholar
• Snowden JA, Kearney P, Kearney A, Cooley HM, Grigg A, Jacobs 54. P, et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998;41: 453–9.
   Google Scholar
• Lowenthal RM, Cohen ML, Atkinson K, Biggs JC. Apparent 55. cure of rheumatoid arthritis by bone marrow transplantation. J Ftheumatol 1993;20:137–40.
   Google Scholar
• McKendry RJR, Huebsch L, Leclair B. Progression of rheumatoid 56. arthritis following bone marrow transplantation. Arthritis Rheum 1996;39: 1246–53.
   Google Scholar
• Nelson JL, Torrez R, Louie FM, Choe OS, Storb R, Sullivan KM. Pre-existing autoimmune disease in patients with long-term sur- 57. vival after allogeneic bone marrow transplantation. J Rheumatol 1997;24 Suppl 48:23–9.
   Google Scholar
• Gur-Lavi M. Long-term remission with allogenic bone marrow transplantation in systemic lupus erythematosus. Arthritis Rheum 58. 1999;42:1777.
   PubMed Web of Science ®Google Scholar
• Minowa R, Miyagawa S, Fukumoto T, Majima T, Shimoyama T, Fujimura Y, et al. Primary Sj8gren's syndrome followed by chronic myelogenous leukemia: a case report with a ten-year history. J 59. Dermatol 1998;25: 460–4.
   Google Scholar
• CetkovskSTP, Koza V, Cetkovskd P, Svojgrová M. Successful treat- 60. ment of severe Shulman's syndrome by allogeneic bone marrow transplantation. Bone Marrow Transplant 1998;21: 637–9.61.
   Google Scholar
• Euler HH, Marmont AM, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht M, et al. Early recurrence or persistence of autoim-mune diseases after unmanipulated autologous stem cell transplan-tation. Blood 1996;88:3621–5.
   PubMed Web of Science ®Google Scholar
• Cooley HM, Snowden JA, Grigg AP, Wicks IP. Outcome of rheu-matoid arthritis and psoriasis following autologous stem cell trans-plantation for hematologic malignancy. Arthritis Rheum 1997;40: 1712–5.
   PubMed Web of Science ®Google Scholar
• Jondeau K, Job-Deslandre C, Bouscary D, Khanlou N, Menkes C-J, Dreyfus F. Remission of nonerosive polyarthritis associated with Sjögren's syndrome after autologous hematopoietic stem cell transplantation for lymphoma. J Ftheumatol 1997;24:2466–8.
   Google Scholar
• Snowden JA, Patton WN, O'Donnell JL, Hannah EE, Hart DNJ. Prolonged remission of long-standing systemic lupus erythemato-sus after autologous bone marrow transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 1997;19:1247–50.
   Google Scholar
• Meloni G, Carpria S, Vignetti M, Mandelli F, Modena V. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood 1997;89: 4659.
   Google Scholar
• Rösler W, Manger B, Repp R, Kalden JR, Gramatzki M. Autolo-gous PBPCT in a patient with lymphoma and Sjögren's syndrome: complete remission of lymphoma without control of the autoim-mune disease. Bone Marrow Transplant 1998;22:211–3.
   Google Scholar
• Joske DJL. Autologous bone-marrow transplantation for rheuma-toid arthritis. Lancet 1997;350:337–8.
   PubMed Web of Science ®Google Scholar
• Durez P, Toungouz M, Schandene, Lambermont M, Goldman M. Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis. Lancet 1998;352:881.
   Google Scholar
• Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, et al. Treatment of autoimmune disease by intense immunosup-pressive conditioning and autologous hematopoietic stem cell transplantation. Blood 1998;92:3505–14.
   PubMed Web of Science ®Google Scholar
• McColl G, Kohsaka H, Szer J, Wicks I. High-dose chemotherapy and syngeneic stem-cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med 1999;131:507–9.
   PubMed Web of Science ®Google Scholar
• Marmont AM, Van Lint MT, Gualandi F, Bacigalupo A. Autolo-gous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997;6:545–8.
   PubMed Web of Science ®Google Scholar
• Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R, et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 1998;7:492–4.
   PubMed Web of Science ®Google Scholar
• Foulllard L, Gorin NC, Laporte JPh, Leon A, Brantus JF, Miossec P. Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood. Lupus 1999;8:320–3.
   Google Scholar
• Trysberg E, Lindgren I, Tarkowski A. Autologous stem cell trans-plantation in a case of treatment-resistant central nervous system lupus. Ann Rheum Dis 2000;59:236–8.
   Google Scholar
• Fassas A, Anagnostopoulos A, Giannaki E, Vadikolia C, Zambouli D, Papaioannou G. Autologous blood stem cell therapy for autoimmune pancytopenia due to systemic lupus erythemato-sus [abstract]. Bone Marrow Transplant 1998;21 Suppl 1:53.
   Google Scholar
• Tyndall A, Black C, Finke J, Winkler J, Mertlesmann R, Peter HH, et al. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet 1997;349:254.
   PubMed Web of Science ®Google Scholar
• Martini A, Maccario R, Ravelli A, Montagna D, De Benedetti F, Bonetti F, et al. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. Arthritis Rheum 1999;42:807–11.
   PubMed Web of Science ®Google Scholar
• Tamm M, Gratwohl A, Tichelli A, Perruchoud AP, Tyndall A. Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tis-sue disease. Ann Rheum Dis 1996;55:779–80.
   Google Scholar
• Baron F, Ftibbens C, Kaye O, Fillet G, Malaise M, Beguin Y. Effective treatment of Jo-l-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. Br J Haematol 2000;110;339–42.
   PubMed Web of Science ®Google Scholar
• Harris ED Jr. Rheumatoid arthritis: pathophysiology and implica-tions for therapy. N Engl J Med 1990;322:1277–89.
   PubMed Web of Science ®Google Scholar
• Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994;56:389–466.
   PubMed Web of Science ®Google Scholar
• Breban M, Dougados M, Picard F, Zompi S, Marolleau J-P, Bocac-cio C, et al. Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hemato-poietic stem cell mobilization in refractory rheumatoid arthritis. Arth Rheum 1999;42: 2275–80.
   Google Scholar
• Kohsaka H, Taniguchi A, Chen PP, Collier WE, Carson DA. The expressed T cell receptor V gene repertoire of rheumatoid arthritis monozygotic twins: rapid analysis by anchored polymerase chain reaction and enzyme-linked immunosorbent assay. Eur J Immunol 1993;23:1895–901.
   Google Scholar
• Mizushima N, Kohsaka H, Nanki T, Collier WE, Carson DA, Miyasaka N. HLA-dependent peripheral T cell receptor (TCR) repertoire formation and its modification by rheumatoid arthritis. Clin Exp Immunol 1997;110:428–33.
   Google Scholar
• Kohsaka H, Carson DA, Miyasaka N. Formation of peripheral immunoreceptor repertoire for antigens: potential relationship to pathogenesis of rheumatoid arthritis. Arthritis Rheum 1998;41: 1911–8.
   Google Scholar
• Traynor AE, Schroeder J, Rosa RM, Cheng D, Stefka J, Mujais S, et al. Treatment of severe systemic lupus erythe-matosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 2000;356:701–7.
   PubMed Web of Science ®Google Scholar
• Furst DE, Clements PJ. Summary of pathogenesis. In: Clements PJ, Furst DE, editors. Systemic sclerosis. Baltimore: Williams & Wilkins; 1996. p. 275–87.
   Google Scholar
• Sullivan KM, Furst DE. The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases. J Ftheumatol 1997;24 Suppl 48:1–4.
   Google Scholar
• Snowden JA, Biggs JC, Milliken ST, Fuller A, Brooks PM. A phase I/II dose escalation study of intensified cyclophosphamide and au-tologous blood stem cell rescue in severe, active rheumatoid arthri-tis. Arthritis Rheum 1999;42:2286–92.
   Google Scholar
• Burt RK, Georganas C, Schroeder J, Tratnor A, Stefka J, Schuening F, et al. Autologous hematopoietic stem cell transplan-tation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum 1999;42:2281–5.
   PubMed Web of Science ®Google Scholar
• Rosen O, Thiel A, Massenkeil G, Hiepe F, Häupl T, Radtke H, et al. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res 2000;2:327–36.
   Google Scholar
• Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the Euro-pean Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997;19:643–5.
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Sensenbrenner LL, Jones RJ. Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood 1996;87:491–4.
   Google Scholar
• Brodsky RA, Petri M, Smith BD, Seifter EJ, Spivak JL, Styler M, et al. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med 1998;129:1031–5.
   PubMed Web of Science ®Google Scholar